Cystatin C as a novel predictor of preterm labor in severe preeclampsia.
- Author:
Krittanont WATTANAVAEKIN
1
;
Maethaphan KITPORNTHERANUNT
;
Chatchai KREEPALA
Author Information
- Publication Type:Original Article
- Keywords: Acute kidney injury; Cystatin C; Low birth weight infant; Preeclampsia; Premature obstetric labor
- MeSH: Acute Kidney Injury; Cohort Studies; Cooperative Behavior; Creatinine; Cystatin C*; Diet; Epidemiology; Female; Gestational Age; Glomerular Filtration Rate; Humans; Infant, Low Birth Weight; Infant, Newborn; Kidney; Obstetric Labor, Premature*; Pre-Eclampsia*; Pregnancy; Renal Insufficiency, Chronic; ROC Curve; Sensitivity and Specificity
- From:Kidney Research and Clinical Practice 2018;37(4):338-346
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: The most common cause of acute kidney injury (AKI) in pregnancy is preeclampsia. Serum cystatin C (CysC) is a potential biomarker of early kidney damage as its levels are not disturbed by volume status changes in pregnancy, and serum CysC levels could serve as a replacement for conventionally used creatinine. In this study, we investigated the serum levels of CysC in severe preeclampsia cases and the associations between CysC levels and poor obstetric outcomes. METHODS: Our cohort included severe preeclampsia patients with a normal serum creatinine level. Creatinine was measured to calculate estimated glomerular filtration rate (eGFR) based on the Cockcroft and Gault, Modification of Diet in Renal Disease Study (MDRD), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations, while CysC was measured to calculated eGFR based on a CysC-based equation. We then evaluated the correlations between serum CysC level, eGFR, and obstetric outcomes. RESULTS: Twenty-six patients were evaluated of which 38.5% delivered preterm and 30.8% had low-birth weight babies. Unlike creatinine-based eGFR and CysC-based eGFR, serum CysC demonstrate significant negative correlation with gestational age. Receiver operating characteristic curve analysis indicated that serum CysC is a potential biomarker of preterm delivery with a cut-off serum level of 1.48 mg/L with 80% sensitivity and 75% specificity. CONCLUSION: GFR estimation using CysC is likely to be inaccurate in pregnancy. However, we found a significant correlation between preterm delivery and serum CysC level. Our results suggest that serum CysC level has the potential to predict preterm delivery in severe preeclampsia patients.
